Similar articles for PMID: 35641279

Year	Number of Results
2006	1
2007	3
2008	1
2009	1
2010	1
2011	1
2012	4
2013	6
2014	6
2015	9
2016	6
2017	14
2018	18
2019	11
2020	19
2021	14
2022	5
2023	1
2024	0

1

Stereotactic Body Radiotherapy for Stage I Lung Cancer With a New Real-time Tumor Tracking System.

Hiroshima Y, Tamaki Y, Sawada T, Ishida T, Yasue K, Shinoda K, Saito T, Kaburagi T, Kiyoshima M, Okumura T, Sakurai H. Hiroshima Y, et al. Anticancer Res. 2022 Jun;42(6):2989-2995. doi: 10.21873/anticanres.15782. Anticancer Res. 2022. PMID: 35641279

2

Outcomes of stereotactic body radiotherapy (SBRT) treatment of multiple synchronous and recurrent lung nodules.

Owen D, Olivier KR, Mayo CS, Miller RC, Nelson K, Bauer H, Brown PD, Park SS, Ma DJ, Garces YI. Owen D, et al. Radiat Oncol. 2015 Feb 18;10:43. doi: 10.1186/s13014-015-0340-9. Radiat Oncol. 2015. PMID: 25889747 Free PMC article.

3

Repeat stereotactic body radiotherapy (SBRT) for local recurrence of non-small cell lung cancer and lung metastasis after first SBRT.

Ogawa Y, Shibamoto Y, Hashizume C, Kondo T, Iwata H, Tomita N, Ogino H. Ogawa Y, et al. Radiat Oncol. 2018 Jul 28;13(1):136. doi: 10.1186/s13014-018-1080-4. Radiat Oncol. 2018. PMID: 30055636 Free PMC article.

4

Clinical commissioning of a new patient positioning system, SyncTraX FX4, for intracranial stereotactic radiotherapy.

Tanabe S, Umetsu O, Sasage T, Utsunomiya S, Kuwabara R, Kuribayashi T, Takatou H, Kawaguchi G, Aoyama H. Tanabe S, et al. J Appl Clin Med Phys. 2018 Nov;19(6):149-158. doi: 10.1002/acm2.12467. Epub 2018 Oct 1. J Appl Clin Med Phys. 2018. PMID: 30273444 Free PMC article.

5

Clinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system.

Katoh N, Soda I, Tamamura H, Takahashi S, Uchinami Y, Ishiyama H, Ota K, Inoue T, Onimaru R, Shibuya K, Hayakawa K, Shirato H. Katoh N, et al. Radiat Oncol. 2017 Jan 5;12(1):3. doi: 10.1186/s13014-016-0742-3. Radiat Oncol. 2017. PMID: 28057036 Free PMC article.

6

A Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups.

Macchia G, Lazzari R, Colombo N, Laliscia C, Capelli G, D'Agostino GR, Deodato F, Maranzano E, Ippolito E, Ronchi S, Paiar F, Scorsetti M, Cilla S, Ingargiola R, Huscher A, Cerrotta AM, Fodor A, Vicenzi L, Russo D, Borghesi S, Perrucci E, Pignata S, Aristei C, Morganti AG, Scambia G, Valentini V, Jereczek-Fossa BA, Ferrandina G. Macchia G, et al. Oncologist. 2020 Feb;25(2):e311-e320. doi: 10.1634/theoncologist.2019-0309. Epub 2019 Oct 10. Oncologist. 2020. PMID: 32043791 Free PMC article.

7

Stereotactic body radiotherapy for central lung tumors.

Rowe BP, Boffa DJ, Wilson LD, Kim AW, Detterbeck FC, Decker RH. Rowe BP, et al. J Thorac Oncol. 2012 Sep;7(9):1394-9. doi: 10.1097/JTO.0b013e3182614bf3. J Thorac Oncol. 2012. PMID: 22843088 Free article.

8

A multi-institutional analysis of fractionated versus single-fraction stereotactic body radiotherapy (SBRT) in the treatment of primary lung tumors: a comparison between two antipodal fractionations.

Alongi F, Nicosia L, Figlia V, De Sanctis V, Mazzola R, Giaj-Levra N, Reverberi C, Valeriani M, Osti MF. Alongi F, et al. Clin Transl Oncol. 2021 Oct;23(10):2133-2140. doi: 10.1007/s12094-021-02619-4. Epub 2021 Apr 10. Clin Transl Oncol. 2021. PMID: 33840047

9

Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity.

Franzese C, Bonu ML, Comito T, Clerici E, Loi M, Navarria P, Franceschini D, Pressiani T, Rimassa L, Scorsetti M. Franzese C, et al. J Cancer Res Clin Oncol. 2020 Sep;146(9):2289-2297. doi: 10.1007/s00432-020-03285-9. Epub 2020 Jun 10. J Cancer Res Clin Oncol. 2020. PMID: 32524292

10

Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer: A Retrospective, Single-Center Study of 55 Patients.

Bhandari RP, Stanford JD, Packianathan S, Duggar WN, Kanakamedala MR, Zhang X, Giri SP, Kumar PP, Harrell LM, Mangana SH, Yang C, Vijayakumar S. Bhandari RP, et al. Oncology. 2016;91(4):194-204. doi: 10.1159/000447540. Epub 2016 Jul 19. Oncology. 2016. PMID: 27427761

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

97 results

Results by year